Expertise in
6
conditions

Soledad Gallego-Melcon

Barcelona, CT, ES 
Expertise in
6
conditions
Barcelona, CT, ES 

Overview

Soledad Gallego-Melcon practices practicing medicine in Barcelona, Spain.

Ms. Gallego-Melcon is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Rhabdomyosarcoma, Mesenchymoma, Adult Soft Tissue Sarcoma, Neuroblastoma, and Orchiectomy.

She is actively involved in clinical research, co-authoring 85 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Barcelona, CT, Spain
Other Locations
Spain
Bellaterra, CT, Spain
Cerdanyola Del Valles, CT 08193, Spain
Alicante, VC, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

International Randomized Phase II Trial of the Combination of Vincristine and Irinotecan With or Without Temozolomide (VI or VIT) in Children and Adults With Refractory or Relapsed Rhabdomyosarcoma
International Randomized Phase II Trial of the Combination of Vincristine and Irinotecan With or Without Temozolomide (VI or VIT) in Children and Adults With Refractory or Relapsed Rhabdomyosarcoma
Enrollment Status: Completed
Publish Date: September 18, 2019
Intervention Type: Drug
Study Phase: Phase 2

85 Total Publications

Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 12, 2025

Frequently Asked Questions about Soledad Gallego-Melcon

Is Soledad Gallego-Melcon a top-rated expert for Rhabdomyosarcoma?

MediFind is an objective health platform that identifies experts based on real-world data. Soledad Gallego-Melcon is classified as an Elite expert for Rhabdomyosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Soledad Gallego-Melcon participate in research or clinical trials?

Yes. Soledad Gallego-Melcon has published 85 articles and abstracts on conditions like Rhabdomyosarcoma. You can view a list of Soledad Gallego-Melcon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Gallego-Melcon's expertise for a condition
ConditionClose
View All 7 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile